Global Chemotherapy-Induced Oral Mucositis Market Report By Treatment Type (Ice Chips(Cryotherapy), Preventive And Supportive Dental Care, Strong Oral Cleaning Procedures, Gels/Rinses), By Distribution Channel (Hospitals, Oncology Centres, Research Institutes, Dental Clinics, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11215904
September 2021
Report Formats:
The global demand for Chemotherapy-Induced Oral Mucositis Market is presumed to reach the market size of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period 2021 - 2027.

Mucositis refers to a complication that occurs when cancer treatments break down the speedily divided epithelial cells lining of the gastro-intestinal tract by leaving the mucosal tissue open to infection and ulceration. This problem is seen majorly in two patient populations is the one with head and neck cancer undertaking radiation therapy to fields concerning the oral cavity and those patients receiving high-dose chemotherapy for treating cancer. Individuals undergoing radiation therapy are repeatedly advised to eat a liquid or soft diet. Oral mucositis is likely the most ordinary, devastating complication of cancer treatments, principally chemotherapy, and radiation. It can lead to numerous problems, including pain, and nutritional problems, consequently of incapability to eat and augmented infection risk due to open sores in the mucosa.

Market Dynamics

The increase in usage of chemotherapeutic agents due to the increasing incidence of cancers is the major factor driving the chemotherapy-induced oral mucositis market. The rise in the number of patients receiving chemotherapy each year leads to a high need for the treatment of oral mucositis. The increased elderly population, as they are more susceptible to cancer, is leading to high demand for the treatment of chemotherapy-induced oral mucositis. Moreover, the rising healthcare expenditure and high prevalence of cancer and oral mucositis in cancer patients across the globe are likely to create growth opportunities for key players of the chemotherapy-induced oral mucositis market in the coming years.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of chemotherapy-induced oral mucositis. The growth and trends of chemotherapy-induced oral mucositis industry provide a holistic approach to this study. 

Market Segmentation

This section of the chemotherapy-induced oral mucositis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Treatment Type
  • Ice Chips(Cryotherapy)
  • Preventive And Supportive Dental Care
  • Strong Oral Cleaning Procedures
  • Gels/Rinses

By Distribution Channel
  • Hospitals
  • Oncology Centres
  • Research Institutes
  • Dental Clinics
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Chemotherapy-Induced Oral Mucositis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Chemotherapy-Induced Oral Mucositis Market Share by Region (Representative Graph)
Global Chemotherapy-Induced Oral Mucositis Market Share


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the chemotherapy-induced oral mucositis market include Izun Pharmaceuticals, Aurora Bioscience, Camurus AB, Prothex Inc., Swedish Orphan Biovitrum AB, Soleva Pharma, Access Pharmaceutical Inc., NeoMedLight, INNOVATION Pharma, Monopar TherapeuticsAccess Pharmaceutical Inc., and Swedish Orphan Biovitrum AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . CHEMOTHERAPY-INDUCED ORAL MUCOSITIS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Treatment Type
           3.7.2 By Distribution Channel
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL CHEMOTHERAPY-INDUCED ORAL MUCOSITIS MARKET ANALYSIS BY TREATMENT TYPE
       6.1 Overview by Treatment Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Treatment Type
       6.4 Ice Chips(Cryotherapy) Market by Regions
       6.6 Preventive And Supportive Dental Care Market by Regions
       6.5 Strong Oral Cleaning Procedures Market by Regions
       6.7 Gels/Rinses Market by Regions
 
7 . GLOBAL CHEMOTHERAPY-INDUCED ORAL MUCOSITIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Historical and Forecast Data
       7.3 Analysis by Distribution Channel
       7.4 Hospitals Market by Regions
       7.5 Oncology Centres Market by Regions
       7.6 Research Institutes Market by Regions
       7.7 Dental Clinics Market by Regions
       7.8 Others Market by Regions
 
8 . GLOBAL CHEMOTHERAPY-INDUCED ORAL MUCOSITIS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE CHEMOTHERAPY-INDUCED ORAL MUCOSITIS COMPANIES
       9.1. Chemotherapy-Induced Oral Mucositis Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF CHEMOTHERAPY-INDUCED ORAL MUCOSITIS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Izun Pharmaceuticals
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Aurora Bioscience
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Camurus AB
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Prothex Inc.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Swedish Orphan Biovitrum AB
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Soleva Pharma
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Access Pharmaceutical Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. NeoMedLight
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. INNOVATION Pharma
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Monopar TherapeuticsAccess Pharmaceutical Inc.
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Swedish Orphan Biovitrum AB
           10.13.1. Company Overview
           10.13.2. Financials
           10.13.3. Products
           10.13.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Treatment Type (USD MN)
  • Ice Chips(Cryotherapy) Market by Geography (USD MN)
  • Preventive And Supportive Dental Care Market by Geography (USD MN)
  • Strong Oral Cleaning Procedures Market by Geography (USD MN)
  • Gels/Rinses Market by Geography (USD MN)
  • Analysis Market by Distribution Channel (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Oncology Centres Market by Geography (USD MN)
  • Research Institutes Market by Geography (USD MN)
  • Dental Clinics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Chemotherapy-Induced Oral Mucositis Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Chemotherapy-Induced Oral Mucositis Report
  • Market Research Process
  • Market Research Methodology
  • Global Chemotherapy-Induced Oral Mucositis Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Treatment Type (USD MN)
  • Ice Chips(Cryotherapy) Market by Geography (USD MN)
  • Preventive And Supportive Dental Care Market by Geography (USD MN)
  • Strong Oral Cleaning Procedures Market by Geography (USD MN)
  • Gels/Rinses Market by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Oncology Centres Market by Geography (USD MN)
  • Research Institutes Market by Geography (USD MN)
  • Dental Clinics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials